Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oseltamivir dosing in pandemic H1N1 influenza
NCT01032837Phase 4Terminated
- Sponsor
- Roche
- Start
- Nov 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of oseltamivir in influenza, sponsored by Roche. Started Nov 2009; status: terminated.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01032837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01032837.